BDBM412826 N-[[4-[4-amino-1-(4-methoxycyclohexyl)pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]methyl]-2-methoxy-benzamid::US10399989, Example 39::US10611766, Example 39

SMILES COc1ccccc1C(=O)NCc1ccc(-c2nn(C3CCC(OC)CC3)c3ncnc(N)c23)cc1

InChI Key InChIKey=VKHLIGZYZGNAAT-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 412826   

TargetTyrosine-protein kinase BTK(Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 1.40nMAssay Description:BTKWT binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. 2.5...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 1.40nMAssay Description:BTKWT binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. 2.5...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 10nMAssay Description:BTKWT binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. 2.5...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 10nMAssay Description:BTKC481S binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 10nMAssay Description:BTKC481S binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 10nMAssay Description:BTKWT binding affinity of each compound tested was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. 2.5...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 550nMAssay Description:EGFR binding affinity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. 2.5 nM Recombinant EGFR, var...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Loxo Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 412826BDBM412826(US10399989, Example 39 | N-[[4-[4-amino-1-(4-metho...)
Affinity DataIC50: 550nMAssay Description:EGFR binding affinity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology. 2.5 nM Recombinant EGFR, var...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent